UPH
Income statement / Annual
Last year (2022), UpHealth, Inc.'s total revenue was $158.80 M,
an increase of 28.28% from the previous year.
In 2022, UpHealth, Inc.'s net income was -$222.94 M.
See UpHealth, Inc.’s key income statements, including revenue, expenses, profit, and income.
| Period |
FY-2022
|
FY-2021
|
FY-2020
|
| Period Ended |
12/31/2022 |
12/31/2021 |
12/31/2020 |
| Operating Revenue |
$158.80 M
|
$123.80 M
|
$5.40 M
|
| Cost of Revenue |
$88.65 M |
$80.21 M |
$1.18 M |
| Gross Profit |
$70.16 M |
$43.59 M |
$4.21 M |
| Gross Profit Ratio |
0.44 |
0.35 |
0.78 |
| Research and Development
Expenses |
$7.89 M
|
$7.30 M
|
$874,000.00
|
| General & Administrative
Expenses |
$55.22 M
|
$58.81 M
|
$4.95 M
|
| Selling & Marketing
Expenses |
$15.95 M
|
$9.28 M
|
$0.00
|
| Selling, General &
Administrative Expenses |
$71.17 M
|
$68.09 M
|
$4.95 M
|
| Other Expenses |
$16.14 M |
$13.04 M |
$320,000.00 |
| Operating Expenses |
$95.20 M |
$88.43 M |
$6.14 M |
| Cost And Expenses |
$183.85 M |
$168.64 M |
$7.32 M |
| Interest Income |
$121,000.00 |
$490,000.00 |
$4,000.00 |
| Interest Expense |
$26.50 M |
$19.52 M |
$134,000.00 |
| Depreciation &
Amortization |
$22.46 M
|
$17.90 M
|
$324,000.00
|
| EBITDA |
-$2.59 M
|
-$26.95 M
|
-$1.60 M
|
| EBITDA Ratio |
-0.02 |
-0.22 |
-0.3 |
| Operating Income Ratio
|
-0.16
|
-0.36
|
-0.36
|
| Total Other
Income/Expenses Net |
-$207.28 M
|
-$297.93 M
|
-$210,000.00
|
| Income Before Tax |
-$232.32 M |
-$342.77 M |
-$2.06 M |
| Income Before Tax Ratio
|
-1.46
|
-2.77
|
-0.38
|
| Income Tax Expense |
-$9.38 M |
-$2.44 M |
$50,000.00 |
| Net Income |
-$222.94 M |
-$340.34 M |
-$2.11 M |
| Net Income Ratio |
-1.4 |
-2.75 |
-0.39 |
| EPS |
-15.17 |
-31.8 |
-0.4 |
| EPS Diluted |
-15.17 |
-31.8 |
-0.4 |
| Weighted Average Shares
Out |
$14.70 M
|
$10.70 M
|
$5.23 M
|
| Weighted Average Shares
Out Diluted |
$14.70 M
|
$10.70 M
|
$5.23 M
|
| Link |
|
|
|
